.jpg?format=webp&width=780)
Researchers have discovered a new treatment for overweight and obesity that combines a procedure less swallowable gastric balloon called the Allurion Balloon with the anti-obesity drug liraglutide. The study evaluated the efficacy and safety of this combination treatment. The balloon, placed without surgery or anesthesia, is filled with liquid in the stomach and naturally passes out of the body after approximately 16 weeks. Liraglutide, a glucagon-like peptide-1 receptor agonist, was added to enhance weight loss. After 16 weeks, participants lost an average of 13kg and 14% of their initial body weight. After liraglutide treatment, they lost an average of 18kg and 19% of their initial body weight. The treatment showed promising results in terms of weight loss and had low adverse event rates, potentially offering a cost-effective intervention for obesity-related health complications.
Like
Save
Share